An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
Open Access
- 1 January 2016
- journal article
- review article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 5 (5) , 1097-1109
Abstract
Introduction : Thea im of the study was to compare adalimumab or golimumab with infliximab in patients with moderately-to-severely active ulcerative colitis (UC). Material and methods : This paper was prepared according to the PRISMA guidelines. The systematic literature search was performed...Keywords
This publication has 43 references indexed in Scilit:
- Meta-analysis/Systematic review Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysisArchives of Medical Science, 2013
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative ColitisGastroenterology, 2012
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2011
- Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab studyAlimentary Pharmacology & Therapeutics, 2010
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive reviewPharmacology & Therapeutics, 2008
- Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitisGut, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Long-Term Failure After Restorative Proctocolectomy for Ulcerative ColitisAnnals of Surgery, 2003
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996